Correlation Between Spectrascience New and Guided Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spectrascience New and Guided Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectrascience New and Guided Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spectrascience New and Guided Therapeutics, you can compare the effects of market volatilities on Spectrascience New and Guided Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectrascience New with a short position of Guided Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectrascience New and Guided Therapeutics.

Diversification Opportunities for Spectrascience New and Guided Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Spectrascience and Guided is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spectrascience New and Guided Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guided Therapeutics and Spectrascience New is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectrascience New are associated (or correlated) with Guided Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guided Therapeutics has no effect on the direction of Spectrascience New i.e., Spectrascience New and Guided Therapeutics go up and down completely randomly.

Pair Corralation between Spectrascience New and Guided Therapeutics

If you would invest  16.00  in Guided Therapeutics on September 2, 2024 and sell it today you would earn a total of  3.00  from holding Guided Therapeutics or generate 18.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Spectrascience New  vs.  Guided Therapeutics

 Performance 
       Timeline  
Spectrascience New 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spectrascience New has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Spectrascience New is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Guided Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Guided Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain technical indicators, Guided Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Spectrascience New and Guided Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spectrascience New and Guided Therapeutics

The main advantage of trading using opposite Spectrascience New and Guided Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectrascience New position performs unexpectedly, Guided Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will offset losses from the drop in Guided Therapeutics' long position.
The idea behind Spectrascience New and Guided Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format